Atlas Trials

Study to Evaluate the Safety and Efficacy of PB-201 in Treatment-naive Patients With Type 2 Diabetes Mellitus

Clinical trial NCT05102149 · UNKNOWN

Trial details

NCT number
NCT05102149
Sponsor
PegBio Co., Ltd.
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus (T2DM)
Start date
2021-09-30
Primary completion
2023-11-01
Enrollment
672

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.